246 related articles for article (PubMed ID: 20658736)
1. Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus.
Hadzi-Mihailovic M; Raybaud H; Monteil R; Cakic S; Djuric M; Jankovic L
J BUON; 2010; 15(2):362-8. PubMed ID: 20658736
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 expression in oral lichen planus.
Hadzi-Mihailovic M; Cakic S; Jankovic S; Raybaud H; Nedeljkovic N; Jankovic L
J BUON; 2012; 17(1):132-7. PubMed ID: 22517707
[TBL] [Abstract][Full Text] [Related]
3. Expression of Fas/FasL in patients with oral lichen planus.
Hadzi-Mihailovic M; Raybaud H; Monteil R; Jankovic L
J BUON; 2009; 14(3):487-93. PubMed ID: 19810143
[TBL] [Abstract][Full Text] [Related]
4. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
5. [Expressions of proliferating cell nuclear antigen, Bcl-2, and Bax in lymphocytes of patients with oral lichen planus].
Lei L; Tan WX; Yu M; Zhou XL
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):946-8. PubMed ID: 19460716
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation of oral lichen planus.
Rajentheran R; McLean NR; Kelly CG; Reed MF; Nolan A
Eur J Surg Oncol; 1999 Oct; 25(5):520-3. PubMed ID: 10527601
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of Bcl-2 and Ki-67 in oral lichen planus and leukoplakia with different degrees of dysplasia.
Pigatti FM; Taveira LA; Soares CT
Int J Dermatol; 2015 Feb; 54(2):150-5. PubMed ID: 25265990
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle regulating mechanisms in oral lichen planus: molecular bases in epithelium predisposed to malignant transformation.
González-Moles MA; Bascones-Ilundain C; Gil Montoya JA; Ruiz-Avila I; Delgado-Rodríguez M; Bascones-Martínez A
Arch Oral Biol; 2006 Dec; 51(12):1093-103. PubMed ID: 16914114
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation.
Ebrahimi M; Wahlin YB; Coates PJ; Sjöström B; Nylander K
J Oral Pathol Med; 2006 Jan; 35(1):46-50. PubMed ID: 16393253
[TBL] [Abstract][Full Text] [Related]
10. Expression of caspase-3 and structural changes associated with apoptotic cell death of keratinocytes in oral lichen planus.
Tobón-Arroyave SI; Villegas-Acosta FA; Ruiz-Restrepo SM; Vieco-Durán B; Restrepo-Misas M; Londoño-López ML
Oral Dis; 2004 May; 10(3):173-8. PubMed ID: 15089928
[TBL] [Abstract][Full Text] [Related]
11. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis of oral epithelial cells in oral lichen planus caused by upregulation of BMP-4.
Kim SG; Chae CH; Cho BO; Kim HN; Kim HJ; Kim IS; Choi JY
J Oral Pathol Med; 2006 Jan; 35(1):37-45. PubMed ID: 16393252
[TBL] [Abstract][Full Text] [Related]
13. Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study.
Safadi RA; Al Jaber SZ; Hammad HM; Hamasha AA
Arch Oral Biol; 2010 Jun; 55(6):454-61. PubMed ID: 20427035
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
Mattila R; Alanen K; Syrjänen S
Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
[TBL] [Abstract][Full Text] [Related]
15. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients.
van der Meij EH; Mast H; van der Waal I
Oral Oncol; 2007 Sep; 43(8):742-8. PubMed ID: 17112770
[TBL] [Abstract][Full Text] [Related]
16. TNF-alpha expression and apoptosis-regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation.
Sklavounou A; Chrysomali E; Scorilas A; Karameris A
J Oral Pathol Med; 2000 Sep; 29(8):370-5. PubMed ID: 10972345
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis and cell cycle arrest in oral lichen planus Hypothesis on their possible influence on its malignant transformation.
Bascones C; Gonzalez-Moles MA; Esparza G; Bravo M; Acevedo A; Gil-Montoya JA; Bascones A
Arch Oral Biol; 2005 Oct; 50(10):873-81. PubMed ID: 16137496
[TBL] [Abstract][Full Text] [Related]
18. Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential.
Szarka K; Tar I; Fehér E; Gáll T; Kis A; Tóth ED; Boda R; Márton I; Gergely L
Oral Microbiol Immunol; 2009 Aug; 24(4):314-8. PubMed ID: 19572894
[TBL] [Abstract][Full Text] [Related]
19. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
20. Update of the cancer-associated molecular mechanisms in oral lichen planus, a disease with possible premalignant nature.
Georgakopoulou EA; Troupis TG; Troupis G; Gorgoulis VG
J BUON; 2011; 16(4):613-6. PubMed ID: 22331711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
